• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNTHES GMBH UNK - CONSTRUCTS: PFNA; ROD, FIXATION, INTRAMEDULLARY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNTHES GMBH UNK - CONSTRUCTS: PFNA; ROD, FIXATION, INTRAMEDULLARY Back to Search Results
Device Problems Use of Device Problem (1670); Device-Device Incompatibility (2919); Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  Injury  
Manufacturer Narrative
Complainant part is not expected to be returned for manufacturer review/investigation.Without a lot number, the device history records review could not be completed as no product was received.The investigation could not be completed, no product was received; no conclusion could be drawn at the time of filing this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Device report from synthes reports an event in (b)(6) as follows: this report is being filed after the review of the following journal article: bonnaire, f., lein, t., fülling, t., and bula, p.(2020), reduced complication rates for unstable trochanteric fractures managed with third-generation nails: gamma 3 nail versus pfna, european journal of trauma and emergency surgery, vol.46 (xx), pages 955¿962 (germany).The aim of this prospective observational and retrospective cohort study is to find out the early (within 6 months) and late complication (up 2.5 years) rate in unstable intertrochanteric fractures stabilized by two different intramedullary cephalocaudal nails in our clinical praxis.Between july 2005 to december 2006, a total of 106 patients were included in the study.Surgery was performed using a proximal femoral nail (pfna) in 53 patients (11 male and 42 female), with an average age of 81 (± 11) years, and a competitor device in 53 patients (16 male and 37 female) with an average age of 83 (± 9) years.Clinical and radiological follow-up assessments were conducted at 6 months after surgery.The mean follow-up period was unknown.The following complications were reported: in 7 patients, reduction in open technique was performed since closed reduction proved difficult.In 15 patients, implant-related intraoperative difficulties were experienced.The three critical factors were: partial reduction loss during nail insertion, implant jamming in the distal medullary cavity because the pfna was too long and persistent intertrochanteric fracture dehiscence.In 2 cases, it was necessary to change to a shorter implant.2 patients had mechanical complications requiring revision.In one patient, there was manifest rotational misalignment that had to be corrected by implant removal and implantation of a total hip replacement.In a second patient, lateralization of the pfna blade was observed and was subsequently replaced with a shorter blade.1 patient had a lateral migration.1 patient suffered renewed trauma to the operated side with severe consequences.The patient fell a second time on the operated side and sustained partial avulsion of the gluteus medius and minimus muscles.This led to the implantation of a total hip replacement.3 patients had superficial wound healing disorders and hematoma requiring revision.15 patients had bladder infection/pneumonia.1 patient had acute coronary syndrome/stroke.20 patients already died after 2.3 years on average.This report is for an unknown synthes pfna constructs, unknown synthes pfna nails, and unknown synthes pfna blade.This report is for (1) unk - constructs: pfna.This is report 2 of 4 (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK - CONSTRUCTS: PFNA
Type of Device
ROD, FIXATION, INTRAMEDULLARY
Manufacturer (Section D)
SYNTHES GMBH
eimattstrasse 3
oberdorf 4436
SZ  4436
Manufacturer Contact
kara ditty-bovard
1302 wright lane east
west chester, PA 19380
6107195000
MDR Report Key11349282
MDR Text Key244213139
Report Number8030965-2021-01166
Device Sequence Number1
Product Code HSB
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial
Report Date 01/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-